1 Study Coverage
1.1 Meningococcal Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polysaccharide
1.2.3 Conjugate
1.2.4 Combination
1.3 Market by Application
1.3.1 Global Meningococcal Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meningococcal Vaccination Sales Estimates and Forecasts 2017-2028
2.2 Global Meningococcal Vaccination Revenue Estimates and Forecasts 2017-2028
2.3 Global Meningococcal Vaccination Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Meningococcal Vaccination Sales by Region
2.4.1 Global Meningococcal Vaccination Sales by Region (2017-2022)
2.4.2 Global Sales Meningococcal Vaccination by Region (2023-2028)
2.5 Global Meningococcal Vaccination Revenue by Region
2.5.1 Global Meningococcal Vaccination Revenue by Region (2017-2022)
2.5.2 Global Meningococcal Vaccination Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Meningococcal Vaccination Sales by Manufacturers
3.1.1 Global Top Meningococcal Vaccination Manufacturers by Sales (2017-2022)
3.1.2 Global Meningococcal Vaccination Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningococcal Vaccination in 2021
3.2 Global Meningococcal Vaccination Revenue by Manufacturers
3.2.1 Global Meningococcal Vaccination Revenue by Manufacturers (2017-2022)
3.2.2 Global Meningococcal Vaccination Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccination Revenue in 2021
3.3 Global Meningococcal Vaccination Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Meningococcal Vaccination Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meningococcal Vaccination Sales by Type
4.1.1 Global Meningococcal Vaccination Historical Sales by Type (2017-2022)
4.1.2 Global Meningococcal Vaccination Forecasted Sales by Type (2023-2028)
4.1.3 Global Meningococcal Vaccination Sales Market Share by Type (2017-2028)
4.2 Global Meningococcal Vaccination Revenue by Type
4.2.1 Global Meningococcal Vaccination Historical Revenue by Type (2017-2022)
4.2.2 Global Meningococcal Vaccination Forecasted Revenue by Type (2023-2028)
4.2.3 Global Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
4.3 Global Meningococcal Vaccination Price by Type
4.3.1 Global Meningococcal Vaccination Price by Type (2017-2022)
4.3.2 Global Meningococcal Vaccination Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Meningococcal Vaccination Sales by Application
5.1.1 Global Meningococcal Vaccination Historical Sales by Application (2017-2022)
5.1.2 Global Meningococcal Vaccination Forecasted Sales by Application (2023-2028)
5.1.3 Global Meningococcal Vaccination Sales Market Share by Application (2017-2028)
5.2 Global Meningococcal Vaccination Revenue by Application
5.2.1 Global Meningococcal Vaccination Historical Revenue by Application (2017-2022)
5.2.2 Global Meningococcal Vaccination Forecasted Revenue by Application (2023-2028)
5.2.3 Global Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
5.3 Global Meningococcal Vaccination Price by Application
5.3.1 Global Meningococcal Vaccination Price by Application (2017-2022)
5.3.2 Global Meningococcal Vaccination Price Forecast by Application (2023-2028)
6 North America
6.1 North America Meningococcal Vaccination Market Size by Type
6.1.1 North America Meningococcal Vaccination Sales by Type (2017-2028)
6.1.2 North America Meningococcal Vaccination Revenue by Type (2017-2028)
6.2 North America Meningococcal Vaccination Market Size by Application
6.2.1 North America Meningococcal Vaccination Sales by Application (2017-2028)
6.2.2 North America Meningococcal Vaccination Revenue by Application (2017-2028)
6.3 North America Meningococcal Vaccination Market Size by Country
6.3.1 North America Meningococcal Vaccination Sales by Country (2017-2028)
6.3.2 North America Meningococcal Vaccination Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Meningococcal Vaccination Market Size by Type
7.1.1 Europe Meningococcal Vaccination Sales by Type (2017-2028)
7.1.2 Europe Meningococcal Vaccination Revenue by Type (2017-2028)
7.2 Europe Meningococcal Vaccination Market Size by Application
7.2.1 Europe Meningococcal Vaccination Sales by Application (2017-2028)
7.2.2 Europe Meningococcal Vaccination Revenue by Application (2017-2028)
7.3 Europe Meningococcal Vaccination Market Size by Country
7.3.1 Europe Meningococcal Vaccination Sales by Country (2017-2028)
7.3.2 Europe Meningococcal Vaccination Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Meningococcal Vaccination Market Size by Type
8.1.1 Asia Pacific Meningococcal Vaccination Sales by Type (2017-2028)
8.1.2 Asia Pacific Meningococcal Vaccination Revenue by Type (2017-2028)
8.2 Asia Pacific Meningococcal Vaccination Market Size by Application
8.2.1 Asia Pacific Meningococcal Vaccination Sales by Application (2017-2028)
8.2.2 Asia Pacific Meningococcal Vaccination Revenue by Application (2017-2028)
8.3 Asia Pacific Meningococcal Vaccination Market Size by Region
8.3.1 Asia Pacific Meningococcal Vaccination Sales by Region (2017-2028)
8.3.2 Asia Pacific Meningococcal Vaccination Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Meningococcal Vaccination Market Size by Type
9.1.1 Latin America Meningococcal Vaccination Sales by Type (2017-2028)
9.1.2 Latin America Meningococcal Vaccination Revenue by Type (2017-2028)
9.2 Latin America Meningococcal Vaccination Market Size by Application
9.2.1 Latin America Meningococcal Vaccination Sales by Application (2017-2028)
9.2.2 Latin America Meningococcal Vaccination Revenue by Application (2017-2028)
9.3 Latin America Meningococcal Vaccination Market Size by Country
9.3.1 Latin America Meningococcal Vaccination Sales by Country (2017-2028)
9.3.2 Latin America Meningococcal Vaccination Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Vaccination Market Size by Type
10.1.1 Middle East and Africa Meningococcal Vaccination Sales by Type (2017-2028)
10.1.2 Middle East and Africa Meningococcal Vaccination Revenue by Type (2017-2028)
10.2 Middle East and Africa Meningococcal Vaccination Market Size by Application
10.2.1 Middle East and Africa Meningococcal Vaccination Sales by Application (2017-2028)
10.2.2 Middle East and Africa Meningococcal Vaccination Revenue by Application (2017-2028)
10.3 Middle East and Africa Meningococcal Vaccination Market Size by Country
10.3.1 Middle East and Africa Meningococcal Vaccination Sales by Country (2017-2028)
10.3.2 Middle East and Africa Meningococcal Vaccination Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 JN-International Medical
11.2.1 JN-International Medical Corporation Information
11.2.2 JN-International Medical Overview
11.2.3 JN-International Medical Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 JN-International Medical Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 JN-International Medical Recent Developments
11.3 Novartis International
11.3.1 Novartis International Corporation Information
11.3.2 Novartis International Overview
11.3.3 Novartis International Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis International Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis International Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Baxter International
11.6.1 Baxter International Corporation Information
11.6.2 Baxter International Overview
11.6.3 Baxter International Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter International Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter International Recent Developments
11.7 Biomed
11.7.1 Biomed Corporation Information
11.7.2 Biomed Overview
11.7.3 Biomed Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biomed Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biomed Recent Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Corporation Information
11.8.2 Serum Institute of India Overview
11.8.3 Serum Institute of India Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Serum Institute of India Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Serum Institute of India Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Meningococcal Vaccination Industry Chain Analysis
12.2 Meningococcal Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meningococcal Vaccination Production Mode & Process
12.4 Meningococcal Vaccination Sales and Marketing
12.4.1 Meningococcal Vaccination Sales Channels
12.4.2 Meningococcal Vaccination Distributors
12.5 Meningococcal Vaccination Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Meningococcal Vaccination Industry Trends
13.2 Meningococcal Vaccination Market Drivers
13.3 Meningococcal Vaccination Market Challenges
13.4 Meningococcal Vaccination Market Restraints
14 Key Findings in The Global Meningococcal Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Meningococcal Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Polysaccharide
Table 3. Major Manufacturers of Conjugate
Table 4. Major Manufacturers of Combination
Table 5. Global Meningococcal Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Meningococcal Vaccination Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Meningococcal Vaccination Sales by Region (2017-2022) & (K Units)
Table 8. Global Meningococcal Vaccination Sales Market Share by Region (2017-2022)
Table 9. Global Meningococcal Vaccination Sales by Region (2023-2028) & (K Units)
Table 10. Global Meningococcal Vaccination Sales Market Share by Region (2023-2028)
Table 11. Global Meningococcal Vaccination Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Meningococcal Vaccination Revenue Market Share by Region (2017-2022)
Table 13. Global Meningococcal Vaccination Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Meningococcal Vaccination Revenue Market Share by Region (2023-2028)
Table 15. Global Meningococcal Vaccination Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Meningococcal Vaccination Sales Share by Manufacturers (2017-2022)
Table 17. Global Meningococcal Vaccination Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Meningococcal Vaccination Revenue Share by Manufacturers (2017-2022)
Table 19. Meningococcal Vaccination Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Meningococcal Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Meningococcal Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccination as of 2021)
Table 22. Meningococcal Vaccination Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Meningococcal Vaccination Product Offered
Table 24. Date of Manufacturers Enter into Meningococcal Vaccination Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 27. Global Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 28. Global Meningococcal Vaccination Sales Share by Type (2017-2022)
Table 29. Global Meningococcal Vaccination Sales Share by Type (2023-2028)
Table 30. Global Meningococcal Vaccination Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Meningococcal Vaccination Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Meningococcal Vaccination Revenue Share by Type (2017-2022)
Table 33. Global Meningococcal Vaccination Revenue Share by Type (2023-2028)
Table 34. Meningococcal Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Meningococcal Vaccination Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 37. Global Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 38. Global Meningococcal Vaccination Sales Share by Application (2017-2022)
Table 39. Global Meningococcal Vaccination Sales Share by Application (2023-2028)
Table 40. Global Meningococcal Vaccination Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Meningococcal Vaccination Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Meningococcal Vaccination Revenue Share by Application (2017-2022)
Table 43. Global Meningococcal Vaccination Revenue Share by Application (2023-2028)
Table 44. Meningococcal Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Meningococcal Vaccination Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 47. North America Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 48. North America Meningococcal Vaccination Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Meningococcal Vaccination Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 51. North America Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 52. North America Meningococcal Vaccination Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Meningococcal Vaccination Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Meningococcal Vaccination Sales by Country (2017-2022) & (K Units)
Table 55. North America Meningococcal Vaccination Sales by Country (2023-2028) & (K Units)
Table 56. North America Meningococcal Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Meningococcal Vaccination Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 59. Europe Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 60. Europe Meningococcal Vaccination Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Meningococcal Vaccination Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 63. Europe Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 64. Europe Meningococcal Vaccination Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Meningococcal Vaccination Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Meningococcal Vaccination Sales by Country (2017-2022) & (K Units)
Table 67. Europe Meningococcal Vaccination Sales by Country (2023-2028) & (K Units)
Table 68. Europe Meningococcal Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Meningococcal Vaccination Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Meningococcal Vaccination Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Meningococcal Vaccination Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Meningococcal Vaccination Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Meningococcal Vaccination Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Meningococcal Vaccination Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Meningococcal Vaccination Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Meningococcal Vaccination Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Meningococcal Vaccination Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Meningococcal Vaccination Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Meningococcal Vaccination Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Meningococcal Vaccination Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Meningococcal Vaccination Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Meningococcal Vaccination Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Meningococcal Vaccination Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Meningococcal Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Meningococcal Vaccination Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Meningococcal Vaccination Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Meningococcal Vaccination Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Meningococcal Vaccination Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Meningococcal Vaccination Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Meningococcal Vaccination Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Meningococcal Vaccination Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Meningococcal Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Meningococcal Vaccination Revenue by Country (2023-2028) & (US$ Million)
Table 106. GlaxoSmithKline Corporation Information
Table 107. GlaxoSmithKline Description and Major Businesses
Table 108. GlaxoSmithKline Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. GlaxoSmithKline Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. GlaxoSmithKline Recent Developments
Table 111. JN-International Medical Corporation Information
Table 112. JN-International Medical Description and Major Businesses
Table 113. JN-International Medical Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. JN-International Medical Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. JN-International Medical Recent Developments
Table 116. Novartis International Corporation Information
Table 117. Novartis International Description and Major Businesses
Table 118. Novartis International Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Novartis International Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Novartis International Recent Developments
Table 121. Sanofi Corporation Information
Table 122. Sanofi Description and Major Businesses
Table 123. Sanofi Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Sanofi Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Sanofi Recent Developments
Table 126. Pfizer Corporation Information
Table 127. Pfizer Description and Major Businesses
Table 128. Pfizer Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Pfizer Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Pfizer Recent Developments
Table 131. Baxter International Corporation Information
Table 132. Baxter International Description and Major Businesses
Table 133. Baxter International Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Baxter International Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Baxter International Recent Developments
Table 136. Biomed Corporation Information
Table 137. Biomed Description and Major Businesses
Table 138. Biomed Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Biomed Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Biomed Recent Developments
Table 141. Serum Institute of India Corporation Information
Table 142. Serum Institute of India Description and Major Businesses
Table 143. Serum Institute of India Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Serum Institute of India Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Serum Institute of India Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Meningococcal Vaccination Distributors List
Table 149. Meningococcal Vaccination Customers List
Table 150. Meningococcal Vaccination Market Trends
Table 151. Meningococcal Vaccination Market Drivers
Table 152. Meningococcal Vaccination Market Challenges
Table 153. Meningococcal Vaccination Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Vaccination Product Picture
Figure 3. Global Meningococcal Vaccination Market Share by Type in 2021 & 2028
Figure 3. Polysaccharide Product Picture
Figure 4. Conjugate Product Picture
Figure 5. Combination Product Picture
Figure 6. Global Meningococcal Vaccination Market Share by Application in 2021 & 2028
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Bacteremia
Figure 10. Others
Figure 11. Meningococcal Vaccination Report Years Considered
Figure 12. Global Meningococcal Vaccination Sales 2017-2028 (K Units)
Figure 13. Global Meningococcal Vaccination Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Meningococcal Vaccination Revenue 2017-2028 (US$ Million)
Figure 15. Global Meningococcal Vaccination Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Meningococcal Vaccination Sales Market Share by Region (2017-2022)
Figure 17. Global Meningococcal Vaccination Sales Market Share by Region (2023-2028)
Figure 18. North America Meningococcal Vaccination Sales YoY (2017-2028) & (K Units)
Figure 19. North America Meningococcal Vaccination Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Meningococcal Vaccination Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Meningococcal Vaccination Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Meningococcal Vaccination Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Meningococcal Vaccination Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Meningococcal Vaccination Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Meningococcal Vaccination Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Meningococcal Vaccination Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Meningococcal Vaccination Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Meningococcal Vaccination Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Meningococcal Vaccination in the World: Market Share by Meningococcal Vaccination Revenue in 2021
Figure 30. Global Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 32. Global Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
Figure 33. Global Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 34. Global Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
Figure 35. North America Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 36. North America Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
Figure 37. North America Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 38. North America Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
Figure 39. North America Meningococcal Vaccination Sales Share by Country (2017-2028)
Figure 40. North America Meningococcal Vaccination Revenue Share by Country (2017-2028)
Figure 41. U.S. Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 44. Europe Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
Figure 45. Europe Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 46. Europe Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
Figure 47. Europe Meningococcal Vaccination Sales Share by Country (2017-2028)
Figure 48. Europe Meningococcal Vaccination Revenue Share by Country (2017-2028)
Figure 49. Germany Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 50. France Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Meningococcal Vaccination Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Meningococcal Vaccination Revenue Share by Region (2017-2028)
Figure 60. China Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 63. India Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 71. Latin America Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 73. Latin America Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Meningococcal Vaccination Sales Share by Country (2017-2028)
Figure 75. Latin America Meningococcal Vaccination Revenue Share by Country (2017-2028)
Figure 76. Mexico Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Meningococcal Vaccination Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Meningococcal Vaccination Revenue Share by Country (2017-2028)
Figure 85. Turkey Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Meningococcal Vaccination Revenue (2017-2028) & (US$ Million)
Figure 88. Meningococcal Vaccination Value Chain
Figure 89. Meningococcal Vaccination Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
